Pamlab

{{Short description|American medical food company}}

{{Multiple issues|{{more footnotes needed|date=June 2014}}

{{notability|Organizations|date=June 2015}}}}

Alfasigma USA, Inc. (formerly Pamlab) is an American medical food company, and a division of Alfasigma Group, of Bologna, Italy.

Alfasigma's base of operations is located in Bedminster, New Jersey.

History

The company entered the pharmaceutical industry in 1957, initially introducing prescription cough/cold products. In 1987, Pamlab was purchased by Samuel and Judith Camp.{{cite web|url=http://www.pamlab.com/human-resources/|title=Our History|publisher=Pamlab|access-date=2016-03-24}}

In early 2013, Pamlab was purchased by Nestlé Health Science.{{cite web|url=https://www.reuters.com/article/nestle-idUSL6N0BQ1BV20130226|title=Nestle buys U.S. medical foods firm Pamlab|publisher=Reuters|date=26 February 2013|access-date=2016-03-24}}

In December 2016, Pamlab was purchased by Alfasigma Group of Bologna, Italy.{{cite web|url=http://www.alfasigma.com/CMSContent/Alfasigma/News/01%20news_sito_alfasigma_ING.pdf|title=Alfasigma Expands Footprint|date=13 January 2017|access-date=18 July 2017|archive-date=22 December 2018|archive-url=https://web.archive.org/web/20181222232036/http://www.alfasigma.com/CMSContent/Alfasigma/News/01%20news_sito_alfasigma_ING.pdf|url-status=dead}}

Legal actions

Alfasigma USA, Inc. was sued by ExeGi Pharma LLC and the Italian inventor of probiotic VSL#3, Claudio De Simone, for making false advertising claims and ownership rights to VSL#3.{{Cite journal|last=Simone|first=C. De|date=2018|title=Letter: what gastroenterologists should know about VSL#3|journal=Alimentary Pharmacology & Therapeutics|volume=47|issue=5|pages=698–699|doi=10.1111/apt.14515|pmid=29417631|issn=1365-2036|doi-access=free}}{{Cite web|url=https://law.justia.com/cases/federal/district-courts/maryland/mddce/8:2015cv01356/316062/927/|title=De Simone v. VSL Pharmaceuticals, Inc. et al, No. 8:2015cv01356 - Document 927 (D. Md. 2019)|website=Justia Law|language=en|access-date=2019-09-01}}{{Cite news|url=https://www.classaction.org/media/starr-et-al-v-vsl-pharmaceuticals-inc-et-al.pdf|title=Class Action}}

According to court documents: "Defendant VSL Inc., and its licensees Alfasigma and Leadiant, having lost the right to sell the De Simone Formulation, decided to manufacture, market, and sell a different, inferior formulation (the “Fraudulent Formulation”) without conducting any tests to determine if the Fraudulent Formulation would be efficacious in any way".  

A scientific article published in Frontiers in Immunology concluded: "These discrepancies may have a major impact on patient safety and on the liability of doctors when they prescribe a probiotic formulation made with different processes at different production sites from the formulation, which generated the original evidence, without properly informing the patients".{{Cite journal|last1=Trinchieri|first1=Vito|last2=Laghi|first2=Luca|last3=Vitali|first3=Beatrice|last4=Parolin|first4=Carola|last5=Giusti|first5=Ilaria|last6=Capobianco|first6=Daniela|last7=Mastromarino|first7=Paola|last8=De Simone|first8=Claudio|date=2017-11-06|title=Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing|journal=Frontiers in Immunology|volume=8|pages=1474|doi=10.3389/fimmu.2017.01474|issn=1664-3224|pmc=5681494|pmid=29163538|doi-access=free }}

A class action related to the VSL#3 scandal was recently opened in the USA.{{Cite web|url=https://www.classaction.org/news/class-action-accuses-pharma-companies-of-secretly-reformulating-vsl3-probiotics-product|title=Class Action Accuses Pharma Companies of Secretly Reformulating VSL#3 Probiotics Product|website=www.classaction.org|date=26 July 2019 |language=en|access-date=2019-09-01}}

Products

Alfasigma USA, Inc. produces medical foods for people with diabetic peripheral neuropathy, early memory loss/Alzheimer's, high-risk pregnancy, depression, and other medical conditions.{{Citation needed|date=August 2022}}

Some of Alfasigma USA's products include the following:

See also

References

{{Reflist}}